Company overview
AltaBioscience offers custom peptide synthesis, DNA oligos, polyclonal and monoclonal antibodies, plus analytical services like amino acid analysis, protein sequencing, and mass spectrometry from its UK-based ISO 9001:2015 laboratory. Protein sequencing and amino acid analysis are accredited to ISO 17025:2017 standards. The company serves pharmaceutical, academic, healthcare, and food industry clients globally with high-quality biochemical products and expertise established since 1973.
UKAS Accredited Laboratory is listed in the NovaPharmaNews Supplier Hub as a Life Science Reagents, Diagnostics & Testing partner serving United States & Americas. Core focus areas include peptide synthesis, amino acid analysis, protein sequencing, custom antibodies, dna oligos.
Industry categories: Life Science Reagents, Diagnostics & Testing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://altabioscience.com
- Categories
- Life Science Reagents, Diagnostics & Testing
- Markets served
- United States & Americas
- Keywords
- peptide synthesis, amino acid analysis, protein sequencing, custom antibodies, dna oligos
Products & technologies
Therapeutic areas
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What analytical services does AltaBioscience provide?
- Services include amino acid analysis (ISO 17025:2017 accredited), N-terminal protein sequencing (ISO 17025:2017 accredited), and mass spectrometry techniques for diverse sample types.
- What are your manufacturing capabilities for pharma R&D?
- Custom peptide synthesis, DNA/oligo synthesis, polyclonal and monoclonal antibodies, plus histone peptide arrays and specialist biochemical reagents.
- What certifications and quality standards do you hold?
- ISO 9001:2015 for the laboratory, ISO 17025:2017 for amino acid analysis and protein sequencing; UKAS accredited lab serving global clients.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
